1.Hao Zhang; Chenglong Liu; Qiushi Chen; Li-An Shen; Wenting Xiao; Jiayi Li; Yonghui Wang; Di Zhu*; Qingwei Zhang*; Jianqi Li* (封面文章）.Discovery of Novel 3-Phenylpiperidine Derivatives Targeting the β-Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD-1 Antibody for the Treatment of Colorectal Cancer. Journal of Medicinal Chemistry, 2023, 66, 1349-1379. DOI: 10.1021/acs.jmedchem.2c01568.

2.Hao Zhang; Chenglong Liu; Di Zhu*; Qingwei Zhang*; Jianqi Li* .Medicinal Chemistry Strategies for the Development of Inhibitors Disrupting β‑Catenin’s Interactions with Its Nuclear Partners,Journal of Medicinal Chemistry, 2023,66,1-31. DOI: 10.1021/acs.jmedchem.2c01016.

3.Li-An Shen; Xinyan Peng; Ya Bao; Chenlong Liu; Hao Zhang; Jianqi Li; Di Zhu*; Qingwei Zhang* .  Design, synthesis and biological evaluation of quercetin derivatives as novel β-catenin/B-cell lymphoma 9 protein−protein interaction inhibitors . European Journal of Medicinal Chemistry, 2023, 2023(247): 115075.DOI: 10.1016/j.ejmech.2022.115075.

4.Xiu Gu; Hao Zhang; Minru Jiao; Bo Han; Zixue Zhang; Jianqi Li; Qingwei Zhang*. Histone deacetylase 6 inhibitors with blood-brain barrier penetration as a potential strategy for CNS-Disorders therapy.European Journal of Medicinal Chemistry, 2022, 229(2022): 114090. DOI: 10.1016/j.ejmech.2021.114090.

5.Guo, Zheng; Zhang, Zixue; Zhang, Yi; Wang, Guan; Huang, Ziyi; Zhang, Qingwei*; Li, Jianqi*.Design, synthesis and biological evaluation of brain penetrant benzazepine-based histone deacetylase 6 inhibitors for alleviating stroke-induced brain infarction. European Journal of Medicinal Chemistry, 2021, 2021(218): 113383. DOI: 10.1016/j.ejmech.2021.113383.

6.Zixue Zhang; Qingwei Zhang*; Hao Zhang; Minru Jiao; Zheng Guo; Xinyan Peng; Lei Fu*; Jianqi Li*. Discovery of quinazolinyl-containing benzamides derivatives as novel HDAC1 inhibitors with in vitro and in vivo antitumor activities. Bioorganic Chemistry, 2021, 2021(117): 105407. DOI: 10.1016/j.bioorg.2021.105407.

7.Zhang, Hao; Bao, Ya; Liu, Chenglong; Li, Jianqi*; Zhu, Di*; Zhang, Qingwei*. Recent advances in beta-catenin/BCL9 protein-protein interaction inhibitors. Future Medicinal Chemistry, 2021, 13(10). DOI: 10.4155/fmc-2020-0357.

8.Zheng-Song Gu; Ying Xiao; Ai-nan Zhou; Qing-Wei Zhang*; Jian-Qi Li. Synthesis and antidepressant-like activity of novel aralkyl piperazine derivatives targeting SSRI/5-HT1A/5-HT7. European Journal of Medicinal Chemistry, 2018, 144: 701-715. DOI: 10.1016/j.ejmech.2017.12.063.

9.Gu, Zheng-Song; Wang, Wen-Tao; Qian, Hao; Zhou, Ai-Nan; Sun, Hong-Bin; Zhang, Qing-Wei*; Li, Jian-Qi*. Synthesis and antidepressant effect of novel aralkyl piperazine and piperidine derivatives targeting SSRI/5-HT1A/5-HT7. Bioorganic & Medicinal Chemistry Letters, 2019, 29(23): 126703.DOI: 10.1016/j.bmcl.2019.126703.

10.Zhang, Qing-Wei*; Jiang, Ling; Wang, Guan; Li, Jian-Qi*. Design, synthesis and neuroprotective effects of Fenazinel derivatives. Chinese Chemical Letters, 2017, 28(7): 1505-1508.DOI: 10.1016/j.cclet.2017.02.003.

11.Xianlian Wang; Yongmei Xu; Zaiwei Zong; Jinna Cai; Chunlin Chen; Qingwei Zhang*; Xun Sun*; Jianqi Li*. Design, synthesis and biological evaluation of novel 5-methyl-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole derivatives as potent potassium-competitive acid blockers.Bioorganic & Medicinal Chemistry, 2022, 64: 116765. DOI: https://doi.org/10.1016/j.bmc.2022.116765.